Pear uses biomaterials + organ-on-a-chip technology to model the spread of cancer for precision medicine. Biomaterials model the local spread of cancer, and a microfluidic circulation system allows the cancer to reach a distant organ. We dose and clear drugs into the device to measure the containment and death of cancer over time. This entire process is visualized using 3D imaging to map the location and health of cancer cells....
Pear uses biomaterials + organ-on-a-chip technology to model the spread of cancer for precision medicine. Biomaterials model the local spread of cancer, and a microfluidic circulation system allows the cancer to reach a distant organ. We dose and clear drugs into the device to measure the containment and death of cancer over time. This entire process is visualized using 3D imaging to map the location and health of cancer cells.
More information

Investors

F6S Alpha UK
Admin
Hoxton Ventures Investor Connect
Admin
Hoxton Ventures Investor Connect We back Europe's best tech companies, before the rest of the world believe

Employees

Duleek Ranatunga
Admin
Duleek Ranatunga CEO I have a background in nanotechnology engineering and clinical statistics. I have worked with small-big pharma